about
What is the best size predictor for dose in the obese child?The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis.Tramadol: keep calm and carry on.The phenylephrine concentration-response relationship for blood pressure after nasal delivery in children.Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.Propofol pharmacokinetic and pharmacodynamic profile and its electroencephalographic interaction with remifentanil in childrenNegligible impact of birth on renal function and drug metabolismAnalgesic effectiveness, pharmacokinetics, and safety of a paracetamol/ibuprofen fixed-dose combination in children undergoing adenotonsillectomy: A randomized, single-blind, parallel group trialCompliance with perioperative prophylaxis guidelines and the use of novel outcome measuresPharmacokinetics of an intravenous bolus dose of clonidine in children undergoing surgeryDosing clonidine for sedation in intensive careModeling the pharmacokinetics and pharmacodynamics of sevoflurane using compartment models in children and adultsAcetaminophen, ibuprofen, and tramadol analgesic interactions after adenotonsillectomyHemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in childrenA manual propofol infusion regimen for neonates and infantsA target concentration strategy to determine ibuprofen dosing in childrenAn open label pilot study of a dexmedetomidine-remifentanil-caudal anesthetic for infant lower abdominal/lower extremity surgery: The T REX pilot studyAcetaminophen pharmacokinetics in severely obese adolescents and young adults
P50
Q47179401-03E13E87-8878-4DF4-8BA8-42ABC7304DFCQ47218740-2B4F0888-1E82-40A8-830E-9719F7C3E5BBQ47276375-4B51D3AD-56A5-409E-ADE3-284DB4F62363Q48134439-50C6FE83-9346-4386-BC41-F8D00238ADB7Q52679295-09344C67-1115-4B61-96F8-1C9A84974007Q57281492-EF8682F1-21FD-4D8C-9974-B618D79B4FE3Q57285855-A0217AC8-3392-41FC-B8E9-CC817C0CB53DQ58106311-860E7A34-2D1F-453D-A90E-A66E6F1D8ACDQ89370129-85814565-F2EC-40EC-80D1-C64C912464D5Q90290193-BA18FD39-EBED-44F6-8FC9-AFA81D9B3F81Q90646787-99FB29DF-3542-4DC2-B485-9A4C459D0B40Q90995832-1E7690B9-A904-4A9B-87BC-6AB4AE467BD7Q90995930-A9DC154F-CCDA-4010-9BEF-34CFB7547A33Q91749336-48751012-AB68-49FA-BDB4-7DD51366C820Q92039995-B136352F-B0AC-43B7-9BBE-DDD129F85B13Q93027936-962F11AC-1B0B-4BAD-835E-3A00A84ADBF7Q93073328-F29D32A6-0DFB-4769-B5EB-F864161F02B8Q93365998-41842093-A99F-4E37-83E2-C2411F6B4112
P50
description
researcher (ORCID 0000-0002-2826-3019)
@en
wetenschapper
@nl
name
Brian J Anderson
@en
Brian J Anderson
@nl
type
label
Brian J Anderson
@en
Brian J Anderson
@nl
prefLabel
Brian J Anderson
@en
Brian J Anderson
@nl
P31
P496
0000-0002-2826-3019